Anna Karbicka
Pomeranian Medical University
12 Papers
28 Citations
Anna Karbicka is an academic researcher from Pomeranian Medical University. The author has contributed to research in topics: Bone marrow & Haematopoiesis. The author has an hindex of 4, co-authored 11 publications.
Chat about Author
Papers
Clinical Evidence That Very Small Embryonic-Like Stem Cells Are Mobilized Into Peripheral Blood in Patients After Stroke
Edyta Paczkowska,Magda Kucia,Dorota Koziarska,Maciej Hałasa,Krzysztof Safranow,Marek Masiuk,Anna Karbicka,Marta Nowik,Przemysław Nowacki,Mariusz Z. Ratajczak,Bogusław Machaliński +10 more
TL;DR: It is concluded that stroke triggers the mobilization of CXCR4+ VSEL SCs that have potential prognostic value in stroke patients, and the potential role of these mobilized cells in brain regeneration requires further study.
221
•Journal Article
Short-term storage of human haematopoietic cells. Influence of air and deoxyribonuclease I.
Bogusław Machaliński,Szołomicka P,Jacek Kijowski,M. Baśkiewicz,Anna Karbicka,Byra E,Marcin Majka,Stefania Giedrys-Kalemba,Ratajczak Mz +8 more
TL;DR: It is reported that the presence of air in the vials, in which hematopoietic cells are stored, improves the survival of clonogenic progenitors and the storage medium itself should be supplemented with DNase I.
14
•Journal Article
Bone marrow morphology during haematopoietic stem cell mobilisation with cyclophosphamide in mice.
TL;DR: The presence of an increased number of leucocytes in the sinusoid lumen in comparison with the control suggested that at that time the migration of haematopoietic cells from the bone marrow had been initiated.
Modified Rio Score with Platform Therapy Predicts Treatment Success with Fingolimod and Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients.
Anna Jamroz-Wiśniewska,Radosław Zajdel,Agnieszka Slowik,Monika Marona,Marcin Wnuk,Monika Adamczyk-Sowa,Bożena Adamczyk,Anetta Lasek-Bal,Przemysław Puz,Arkadiusz Stęposz,Ewa Krzystanek,Maja Patalong-Ogiewa,Anna Pokryszko-Dragan,Sławomir Budrewicz,Dorota Koziarska,Anna Karbicka,Sławomir Wawrzyniak,Waldemar Fryze,Marzena Furtak-Niczyporuk,Konrad Rejdak +19 more
TL;DR: In this article, the authors identify factors that would predict poor response to treatment with natalizumab and fingolimod and conclude that switching to the second-line therapy should occur earlier to enable better results for patients treated with Natalizumaab or fingolinimod.
6
Morphology of the bone marrow, spleen and liver during hematopoietic cell mobilization with cyclophosphamide in mice.
Kamila Barcew,Anna Karbicka,Paweł Szumilas,Mariola Marchlewicz,Ryszard Grzegrzółka,Barbara Wiszniewska,Bogusław Machaliński +6 more
TL;DR: It was confirmed, that the egress of HSPC from the bone marrow into the peripheral blood was delayed compared to mice treated with G-CSF or GCS-F plus CY.